Quarterly report pursuant to Section 13 or 15(d)

Restricted Cash Equivalents and Investments (Tables)

v3.22.2.2
Restricted Cash Equivalents and Investments (Tables)
6 Months Ended
Jun. 30, 2022
Restricted Cash Equivalents and Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Securities

June 30, 2022

Amortized Cost

Gross Unrealized
Gains

Gross Unrealized
Losses

Fair Value

Cash Equivalents

Short-Term
Investments

Long-Term
Investments

Cash equivalents:

Money Market Funds

$

695,000 

$

$

$

695,000 

$

695,000 

$

$

Subtotal

695,000 

695,000 

695,000 

Investments:

Corporate Notes/Bonds

2,885,000 

(71,000)

2,814,000 

1,463,000 

1,351,000 

Subtotal

2,885,000 

(71,000)

2,814,000 

1,463,000 

1,351,000 

Total

$

3,580,000 

$

$

(71,000)

$

3,509,000 

$

695,000 

$

1,463,000 

$

1,351,000 

Schedule of Estimated Fair Value of Available-for-Sale Securities

Amortized Cost

Estimated Market
Value

Due within one year

$

1,487,000

$

1,463,000

Due after one year through five years

1,398,000

1,351,000

$

2,885,000

$

2,814,000